{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:21:58Z","timestamp":1793042518955,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23969"],"award-info":[{"award-number":["23969"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008909","name":"Universitatea de Medicin\u0103 \u015fi Farmacie din T\u00eergu Mure\u0219","doi-asserted-by":"publisher","award":["4322\/01.10.2018"],"award-info":[{"award-number":["4322\/01.10.2018"]}],"id":[{"id":"10.13039\/501100008909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.fct.2023.114314","type":"journal-article","created":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T07:37:01Z","timestamp":1701589021000},"page":"114314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Lactobacillus rhamnosus probiotic treatment modulates gut and liver inflammatory pathways in a hepatocellular carcinoma murine model. A preliminary study"],"prefix":"10.1016","volume":"183","author":[{"given":"Iuliana","family":"Nenu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Baldea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8362-6639","authenticated-orcid":false,"given":"Camelia Alexandra","family":"Coad\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5872-8630","authenticated-orcid":false,"given":"Rare\u015f C\u0103lin","family":"Cr\u0103ciun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remus","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-8586","authenticated-orcid":false,"given":"Diana","family":"Tudor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobe","family":"Petrushev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-2559","authenticated-orcid":false,"given":"Vlad Alexandru","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horia","family":"\u015etefanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Procope\u0163","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Sp\u00e2rchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Vodnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Lenghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Clichici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-4925","authenticated-orcid":false,"given":"Gabriela Adriana","family":"Filip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2023.114314_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00603","article-title":"Lactobacillus rhamnosus GG: an overview to explore the rationale of its use in cancer","volume":"8","author":"Banna","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fct.2023.114314_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fct.2023.114314_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-022-03643-9","article-title":"Probiotics and their beneficial effects on alcohol-induced liver injury in a rat model: the role of fecal microbiota","volume":"22","author":"Chayanupatkul","year":"2022","journal-title":"BMC Complement Med. Ther."},{"key":"10.1016\/j.fct.2023.114314_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10010092","article-title":"IL-1\u03b1 processing, signaling and its role in cancer progression","volume":"10","author":"Chiu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.fct.2023.114314_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2021.10.024","article-title":"Induction of IL-6r\u03b1 by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma","volume":"524","author":"Dai","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.fct.2023.114314_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu11122913","article-title":"Side effects associated with probiotic use in adult patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Dore","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.fct.2023.114314_bib7","first-page":"4557","article-title":"A guide to histomorphological evaluation of intestinal inflammation in mouse models","volume":"7","author":"Erben","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.fct.2023.114314_bib8","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/acschembio.9b00663","article-title":"Targeting regorafenib-induced toxicity through inhibition of gut microbial \u03b2-glucuronidases","volume":"14","author":"Ervin","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.fct.2023.114314_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101917","article-title":"Regorafenib plus nivolumab in patients with mismatch repair-proficient\/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study","volume":"58","author":"Fakih","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.fct.2023.114314_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.00477","article-title":"A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function","volume":"10","author":"Gao","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.fct.2023.114314_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/2162402X.2018.1474319","article-title":"Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study","volume":"7","author":"Isambert","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.fct.2023.114314_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41416-021-01467-x","article-title":"The gut microbiome: what the oncologist ought to know","volume":"125","author":"Lee","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.fct.2023.114314_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2022.873160","article-title":"Hepatocellular carcinoma: how the gut microbiota contributes to pathogenesis, diagnosis, and therapy","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.fct.2023.114314_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imr.12615","article-title":"Function and regulation of IL-1\u03b1 in inflammatory diseases and cancer","volume":"281","author":"Malik","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.fct.2023.114314_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MCG.0b013e318291f237","article-title":"Hepatocellular carcinoma: histologic considerations: pure, mixed, and motley","volume":"47","author":"Mitchell","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.fct.2023.114314_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.24953\/turkjped.2018.05.003","article-title":"Effects of Lactobacillus rhamnosus gg as a probiotic on neonatal hyperbilirubinemia","volume":"60","author":"Mutlu","year":"2018","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.fct.2023.114314_bib17","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1007\/s13277-015-3639-0","article-title":"Current position of TNF-\u03b1 in melanomagenesis","volume":"36","author":"Nenu","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.fct.2023.114314_bib18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6603990","article-title":"Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study","volume":"97","author":"\u00d6sterlund","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.fct.2023.114314_bib19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1073\/pnas.0910307107","article-title":"Probiotics promote gut health through stimulation of epithelial innate immunity","volume":"107","author":"Pagnini","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2023.114314_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in non-alcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2023.114314_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835919848184","article-title":"Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma","volume":"11","author":"Ponziani","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.fct.2023.114314_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2023.114314_bib23","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2023.114314_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC \u2013 mechanisms, diagnosis and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2023.114314_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2023.114314_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2023.114314_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10050903","article-title":"Ultrasound or sectional imaging techniques as screening tools for hepatocellular carcinoma: fall forward or move forward?","volume":"10","author":"Sparchez","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.fct.2023.114314_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.fct.2023.114314_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12664-020-01114-y","article-title":"Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation","volume":"40","author":"Tam","year":"2021","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.fct.2023.114314_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ph15101293","article-title":"The probiotic strains bifid\u03bfbacterium lactis, Lactobacillus acidophilus, lactiplantibacillus plantarum and Saccharomyces boulardii regulate wound healing and chemokine responses in human intestinal subepithelial myofibroblasts","volume":"15","author":"Tarapatzi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.fct.2023.114314_bib31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/01635581.2013.741746","article-title":"Probiotics Lactobacillus rhamnosus GG , Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in sprague dawley rats","volume":"65","author":"Verma","year":"2013","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.fct.2023.114314_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/hbsn.2017.12.07","article-title":"Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy","volume":"7","author":"Wan","year":"2018","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.fct.2023.114314_bib33","article-title":"Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase ib\/II clinical trial and gut microbiome analysis","volume":"2","author":"Wang","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.fct.2023.114314_bib34","first-page":"2021","article-title":"RNA-seq and in vitro experiments reveal the protective effect of curcumin against 5-fluorouracil-induced intestinal mucositis via IL-6\/STAT3 signaling pathway","author":"Wang","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.fct.2023.114314_bib35","article-title":"The synergistic antitumor effect of IL-6 neutralization with NVP-BEZ235 in hepatocellular carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.fct.2023.114314_bib36","first-page":"11","article-title":"IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.fct.2023.114314_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.760971","article-title":"IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.fct.2023.114314_bib38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.21873\/anticanres.13996","article-title":"Relationship between adverse events and microbiomes in advanced hepatocellular carcinoma patients treated with sorafenib","volume":"40","author":"Yamamoto","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.fct.2023.114314_bib39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11596-013-1177-9","article-title":"Impact of probiotics on toll-like receptor 4 expression in an experimental model of ulcerative colitis","volume":"33","author":"Yang","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technol. - Med. Sci."},{"key":"10.1016\/j.fct.2023.114314_bib40","first-page":"1","article-title":"Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model","volume":"10","author":"Yeung","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.fct.2023.114314_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12876-019-1047-4","article-title":"A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer","volume":"19","author":"Zaharuddin","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.fct.2023.114314_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2020.03.027","article-title":"Microbiota-derived SSL6 enhances the sensitivity of hepatocellular carcinoma to sorafenib by down-regulating glycolysis","volume":"481","author":"Zhang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.fct.2023.114314_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0650-9","article-title":"Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma","volume":"7","author":"Zheng","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.fct.2023.114314_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0650-9","article-title":"Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma","volume":"7","author":"Zheng","year":"2019","journal-title":"J. Immunother. Cancer"}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523007160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523007160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:25:59Z","timestamp":1759530359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691523007160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":44,"alternative-id":["S0278691523007160"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2023.114314","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactobacillus rhamnosus probiotic treatment modulates gut and liver inflammatory pathways in a hepatocellular carcinoma murine model. A preliminary study","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2023.114314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"114314"}}